DO PRESCRIBERS KNOW THE RESULTS OF KEY CLINICAL-TRIALS

被引:11
|
作者
REVEILLEAU, S
BOISSEL, JP
ALAMERCERY, Y
机构
[1] Unité de Pharmacologie Clinique, 162 avenue Lacassagne, Lyon
关键词
PRESCRIPTION SURVEY; GENERAL PRACTICE; PERTINENT INFORMATION; CLINICAL TRIAL;
D O I
10.1111/j.1472-8206.1991.tb00721.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A survey was run on a sample of 134 French GPs from the Rhone-Alpes region, in an attempt to investigate the way they recollect important clinical trials that should have an impact on their practice. It was found that 1) most of them did not remember these trials (however, the awareness score did vary throughout the trials); 2) the correlation between prescription claims and awareness score was very poor.
引用
收藏
页码:265 / 273
页数:9
相关论文
共 50 条
  • [21] TACRINE DEVELOPMENT EXPERIENCE - EARLY CLINICAL-TRIALS AND ENRICHMENT AND PARALLEL DESIGNS
    SCHNEIDER, LS
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1994, 8 : S12 - S21
  • [22] MONITORING OF CLINICAL-TRIALS AND INTERIM ANALYSES - 2-STATISTICAL METHODS
    BOUTITIE, F
    BELLISSANT, E
    BLANCHARD, J
    BOISSEL, JP
    CAUQUIL, J
    CHAUVIN, F
    DERZKO, G
    DUCRUET, T
    DURRLEMAN, S
    GIRRE, JP
    LEIZOROVICZ, A
    MOCCATTI, D
    MUNOZ, A
    THERAPIE, 1992, 47 (04): : 351 - 355
  • [23] Clinical trials evaluating transtympanic otoprotectants for cisplatin-induced ototoxicity: what do we know so far?
    Waissbluth, Sofia
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2020, 277 (09) : 2413 - 2422
  • [24] Advances in Clinical Cardiology 2022: A Summary of Key Clinical Trials
    Savage, Patrick
    Cox, Brian
    Shahmohammadi, Michael
    Foster, Johnathan
    Menown, Ian
    ADVANCES IN THERAPY, 2023, 40 (06) : 2595 - 2625
  • [25] Advances in Clinical Cardiology 2022: A Summary of Key Clinical Trials
    Patrick Savage
    Brian Cox
    Michael Shahmohammadi
    Johnathan Foster
    Ian Menown
    Advances in Therapy, 2023, 40 : 2595 - 2625
  • [26] Clinical trials evaluating transtympanic otoprotectants for cisplatin-induced ototoxicity: what do we know so far?
    Sofia Waissbluth
    European Archives of Oto-Rhino-Laryngology, 2020, 277 : 2413 - 2422
  • [27] MEASUREMENT ERRORS IN STANDARD VISUAL ANALYSIS OF CORONARY ANGIOGRAMS - CONSEQUENCES ON CLINICAL-TRIALS
    BAIRATI, I
    ROY, L
    MEYER, F
    CANADIAN JOURNAL OF CARDIOLOGY, 1993, 9 (03) : 225 - 230
  • [28] MONITORING OF CLINICAL-TRIALS AND INTERIM ANALYSES .1. THE DATA MONITORING COMMITTEE
    BOUTITIE, F
    BELLISSANT, E
    BLANCHARD, J
    BOISSEL, JP
    CAUQUIL, J
    CHAUVIN, F
    DERZKO, G
    DUCRUET, T
    DURRLEMAN, S
    GIRRE, JP
    LEIZOROVICZ, A
    MOCCATTI, D
    MUNOZ, A
    THERAPIE, 1992, 47 (04): : 345 - 349
  • [29] SAFETY PROFILE OF OFLOXACIN (OFL) IN CLINICAL-TRIALS IN FRANCE FROM 1986 TO 1989
    JOURDAN, J
    DELVAL, C
    MEDECINE ET MALADIES INFECTIEUSES, 1991, 21 (06): : 359 - 362